Skip to main content

Articles

Page 34 of 70

  1. This review aims to provide a comprehensive overview of the literature and elucidate open questions for future clinical trials concerning diagnostics and treatment modalities for cervical cancer of unknown pri...

    Authors: Jens Müller von der Grün, Aykut Tahtali, Shahram Ghanaati, Claus Rödel and Panagiotis Balermpas
    Citation: Radiation Oncology 2017 12:82
  2. A knowledge based planning tool has been developed and implemented for prostate VMAT radiotherapy plans providing a target average rectum dose value based on previously achievable values for similar rectum/PTV...

    Authors: Richard Powis, Andrew Bird, Matthew Brennan, Susan Hinks, Hannah Newman, Katie Reed, John Sage and Gareth Webster
    Citation: Radiation Oncology 2017 12:81
  3. Type-C dose algorithms provide more accurate dosimetry for lung SBRT treatment planning. However, because current dosimetric protocols were developed based on conventional algorithms, its applicability for the...

    Authors: Christina Zhou, Nathan Bennion, Rongtao Ma, Xiaoying Liang, Shuo Wang, Kristina Zvolanek, Megan Hyun, Xiaobo Li, Sumin Zhou, Weining Zhen, Chi Lin, Andrew Wahl and Dandan Zheng
    Citation: Radiation Oncology 2017 12:80
  4. Patients with glioblastoma multiforme (GBM) require radiotherapy as part of definitive management. Our institution has adopted the use of volumetric arc therapy (VMAT) due to superior sparing of the adjacent o...

    Authors: Tina Marie Briere, Mary Frances McAleer, Lawrence B. Levy and James N. Yang
    Citation: Radiation Oncology 2017 12:79
  5. The cumulative dose was compared with the planned dose among fourteen patients undergoing image-guided, intensity-modulated radiotherapy of the prostate bed. Moreover, we investigated the feasibility of adding...

    Authors: Lucia Clara Orlandini, Marianna Coppola, Christian Fulcheri, Luna Cernusco, Pei Wang and Luca Cionini
    Citation: Radiation Oncology 2017 12:78
  6. Glioblastoma is usually diagnosed around the age of 60–70 years. Patients older than 65 years are frequently described as “elderly”. Several trials with monotherapy have established treatment regimens that off...

    Authors: Christoph Straube, Hagen Scherb, Jens Gempt, Stefanie Bette, Claus Zimmer, Friederike Schmidt-Graf, Jürgen Schlegel, Bernhard Meyer and Stephanie E. Combs
    Citation: Radiation Oncology 2017 12:77
  7. The aim of this study was to compare radiotherapy plans for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL) using helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), Fixed-Field intensit...

    Authors: Xianfeng Liu, Erliang Huang, Ying Wang, Yanan He, Huanli Luo, Mingsong Zhong, Da Qiu, Chao Li, Han Yang, Guanglei He, Juan Zhou and Fu Jin
    Citation: Radiation Oncology 2017 12:76
  8. Combined radiotherapy and hyperthermia is a well-established alternative to chemoradiotherapy for advanced stage cervical cancer patients with a contraindication for chemotherapy. Pre-clinical evidence suggest...

    Authors: Caspar M. van Leeuwen, Arlene L. Oei, Kenneth W. T. K. Chin, Johannes Crezee, Arjan Bel, Anneke M. Westermann, Marrije R. Buist, Nicolaas A. P. Franken, Lukas J. A. Stalpers and H. Petra Kok
    Citation: Radiation Oncology 2017 12:75
  9. To evaluate a knowledge based planning model for RapidPlan (RP) generated for advanced head and neck cancer (HNC) patient treatments, as well its ability to possibly improve the clinical plan quality. The stab...

    Authors: A. Fogliata, G. Reggiori, A. Stravato, F. Lobefalo, C. Franzese, D. Franceschini, S. Tomatis, P. Mancosu, M. Scorsetti and L. Cozzi
    Citation: Radiation Oncology 2017 12:73
  10. In patients with head-neck cancer treated with IMRT, immobility of the upper part of the body during radiation is maintained by means of customised immobilisation devices.

    Authors: Massimiliano Contesini, Monica Guberti, Roberta Saccani, Luca Braglia, Cinzia Iotti, Andrea Botti, Emilio Abbati and Marina Iemmi
    Citation: Radiation Oncology 2017 12:72
  11. This is the first known study examining renal function following stereotactic body radiotherapy (SBRT) for pancreatic head adenocarcinoma.

    Authors: Vivek Verma, Abhijeet R. Bhirud, Kyle A. Denniston, Nathan R. Bennion and Chi Lin
    Citation: Radiation Oncology 2017 12:71
  12. It is useful to predict planned dosimetry and determine the eligibility of a liver cancer patient for SBRT treatment using knowledge based planning (KBP). We compare the predictive accuracy using the overlap v...

    Authors: Angelia Tran, Kaley Woods, Dan Nguyen, Victoria Y. Yu, Tianye Niu, Minsong Cao, Percy Lee and Ke Sheng
    Citation: Radiation Oncology 2017 12:70
  13. Twelve years ago, a randomized trial demonstrated that a radiosurgery boost added to whole-brain radiotherapy (WBRT) improved intracerebral control (IC) in patients with one to three cerebral metastases. Overa...

    Authors: Dirk Rades, Stefan Janssen, Amira Bajrovic, Mai Trong Khoa, Theo Veninga and Steven E. Schild
    Citation: Radiation Oncology 2017 12:69
  14. The management of solely intracanalicular acoustic neurinoma (iAN) includes observation, microsurgical resection and radiation therapy. Treatment goals are long-term tumor control, hearing preservation and con...

    Authors: Daniel Rueß, Lea Pöhlmann, Stefan Grau, Christina Hamisch, Alexandra Hellerbach, Harald Treuer, Martin Kocher and Maximilian I. Ruge
    Citation: Radiation Oncology 2017 12:68
  15. We aimed to identify subventricular zone (SVZ)-related prognostic factors of survival and patterns of recurrence among patients with glioblastoma.

    Authors: J. Khalifa, F. Tensaouti, A. Lusque, B. Plas, J.-A. Lotterie, A. Benouaich-Amiel, E. Uro-Coste, V. Lubrano and E. Cohen-Jonathan Moyal
    Citation: Radiation Oncology 2017 12:67
  16. To evaluate the incidence of chest wall toxicity after lung stereotactic ablative radiotherapy (SABR) and identify risk factors for the development of rib fracture.

    Authors: Younghee Park, Hee Jung Kim and Ah Ram Chang
    Citation: Radiation Oncology 2017 12:66

    The Erratum to this article has been published in Radiation Oncology 2017 12:121

  17. For cervical carcinoma cases, this study aimed to evaluate the quality of intensity-modulated radiation therapy (IMRT) plans optimized by biological constraints. Furthermore, a new integrated strategy in biolo...

    Authors: Ziwei Feng, Cheng Tao, Jian Zhu, Jinhu Chen, Gang Yu, Shaohua Qin, Yong Yin and Dengwang Li
    Citation: Radiation Oncology 2017 12:64
  18. Motion monitoring is essential when treating non-static tumours with pencil beam scanned protons. 4D medical imaging typically relies on the detected body surface displacement, considered as a surrogate of the...

    Authors: Giovanni Fattori, Sairos Safai, Pablo Fernández Carmona, Marta Peroni, Rosalind Perrin, Damien Charles Weber and Antony John Lomax
    Citation: Radiation Oncology 2017 12:63
  19. This study aimed to evaluate the efficacy of a high dose of oral tegafur-uracil (400 mg/m2) plus leucovorin with preoperative chemoradiation of locally advanced rectal cancer and to explore the impact of polymorp...

    Authors: Sun Young Kim, Ji Yeon Baek, Jae Hwan Oh, Sung Chan Park, Dae Kyung Sohn, Min Ju Kim, Hee Jin Chang, Sun-Young Kong and Dae Yong Kim
    Citation: Radiation Oncology 2017 12:62
  20. For stereotactic body radiation therapy (SBRT) of liver tumors, tumor motion induced by respiration must be taken into account in planning and treatment. We evaluated whether liver tumor motion at the planning...

    Authors: Yoshinobu Shimohigashi, Ryo Toya, Tetsuo Saito, Osamu Ikeda, Masato Maruyama, Keisuke Yonemura, Yuji Nakaguchi, Yudai Kai, Yasuyuki Yamashita, Natsuo Oya and Fujio Araki
    Citation: Radiation Oncology 2017 12:61
  21. It is currently unclear whether patients with low risk breast cancer receiving adjuvant endocrine therapy need adjuvant radiation therapy after breast conserving surgery. The data of randomized trials are avai...

    Authors: Christiane Matuschek, Edwin Bölke, Jan Haussmann, Svjetlana Mohrmann, Carolin Nestle-Krämling, Peter Arne Gerber, Stefanie Corradini, Klaus Orth, Kai Kammers and Wilfried Budach
    Citation: Radiation Oncology 2017 12:60
  22. Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous cell carcinoma (SCC) requires randomized clinical trials with large sample size, potentially involving different trea...

    Authors: Sarah Differding, Edmond Sterpin, Nicolas Hermand, Bianca Vanstraelen, Sandra Nuyts, Nathalie de Patoul, Jean-Marc Denis, John Aldo Lee and Vincent Grégoire
    Citation: Radiation Oncology 2017 12:59
  23. The delineation of pancreatic tumors on CT is challenging. In this study, we quantified the interobserver variation for pancreatic tumor delineation on 3DCT as well as on 4DCT.

    Authors: Eva Versteijne, Oliver J. Gurney-Champion, Astrid van der Horst, Eelco Lens, M. Willemijn Kolff, Jeroen Buijsen, Gati Ebrahimi, Karen J. Neelis, Coen R. N. Rasch, Jaap Stoker, Marcel van Herk, Arjan Bel and Geertjan van Tienhoven
    Citation: Radiation Oncology 2017 12:58
  24. Autophagy is an important catabolic process in which cells digest and recycle their own cytoplasmic contents for maintaining cellular homeostasis. Interestingly, autophagy could play both pro-death and pro-sur...

    Authors: Shing Yau Tam, Vincent Wing Cheung Wu and Helen Ka Wai Law
    Citation: Radiation Oncology 2017 12:57
  25. Prostate cancer can be treated with several different modalities, including radiation treatment. Various prognostic tools have been developed to aid decision making by providing estimates of the probability of...

    Authors: Elspeth Raymond, Michael E. O’Callaghan, Jared Campbell, Andrew D. Vincent, Kerri Beckmann, David Roder, Sue Evans, John McNeil, Jeremy Millar, John Zalcberg, Martin Borg and Kim Moretti
    Citation: Radiation Oncology 2017 12:56
  26. To improve local control rate in patients with breast cancer receiving adjuvant radiotherapy after breast conservative surgery, additional boost dose to the tumor bed could be delivered simultaneously via the ...

    Authors: Peng-Yi Lee, Chih-Yuan Lin, Shang-Wen Chen, Chun-Ru Chien, Chun-Nan Chu, Hsiu-Ting Hsu, Ji-An Liang, Ying-Jun Lin and An-Cheng Shiau
    Citation: Radiation Oncology 2017 12:55
  27. Accurate and quantitative dosimetry for internal radiation therapy can be especially challenging, given the heterogeneity of patient anatomy, tumor anatomy, and source deposition. Internal radiotherapy sources...

    Authors: Andrew B. Satterlee, Peter Attayek, Bentley Midkiff and Leaf Huang
    Citation: Radiation Oncology 2017 12:54
  28. Low-dose-rate permanent prostate brachytherapy (PPB) is an attractive treatment option for patients with localised prostate cancer with excellent outcomes. As standard CT-based post-implant dosimetry often cor...

    Authors: Sarah O. S. Osman, Simon Horn, Darren Brady, Stephen J. McMahon, Ahamed B. Mohamed Yoosuf, Darren Mitchell, Karen Crowther, Ciara A. Lyons, Alan R. Hounsell, Kevin M. Prise, Conor K. McGarry, Suneil Jain and Joe M. O’Sullivan
    Citation: Radiation Oncology 2017 12:53
  29. The range shifter (RS) is used to treat shallow tumors for a proton pencil beam scanning system (PBS). Adding RS certainly complicates the commissioning of the treatment planning system (TPS) because the spot ...

    Authors: Jiajian Shen, Jarrod M. Lentz, Yanle Hu, Wei Liu, Danairis Hernandez Morales, Joshua B. Stoker and Martin Bues
    Citation: Radiation Oncology 2017 12:52
  30. Previous data from our institution showed that hypofractionated thoracic radiotherapy (HypoTRT) with concurrent etoposide/platinum chemotherapy yielded favorable survival in patients with limited-stage small c...

    Authors: Jing Zhang, Min Fan, Di Liu, Kuai-Le Zhao, Kai-Liang Wu, Wei-Xin Zhao, Zheng-Fei Zhu and Xiao-Long Fu
    Citation: Radiation Oncology 2017 12:51
  31. This study aimed to investigate the tolerability and impact of milk of magnesia (MoM) on interfraction rectal filling during prostate cancer radiotherapy.

    Authors: Ali Hosni, Tara Rosewall, Timothy Craig, Vickie Kong, Andrew Bayley, Alejandro Berlin, Robert Bristow, Charles Catton, Padraig Warde and Peter Chung
    Citation: Radiation Oncology 2017 12:50
  32. Optimal management of locally recurrent prostate cancer after definitive radiation therapy is still challenging. With the development of highly accurate radiotherapy devices, prostate salvage re-irradiation mi...

    Authors: Aurélie Mbeutcha, Laurent Chauveinc, Pierre-Yves Bondiau, Marie-Eve Chand, Matthieu Durand, Daniel Chevallier, Jean Amiel, Daniel Lam Cham Kee and Jean-Michel Hannoun-Lévi
    Citation: Radiation Oncology 2017 12:49
  33. Patients with locally advanced colon cancer (LACC) have a relatively poor prognosis despite radical resection and adjuvant chemotherapy. This study investigated the treatment efficacy and toxicity of neoadjuva...

    Authors: Chun-Ming Huang, Ming-Yii Huang, Cheng-Jen Ma, Yung –Sung Yeh, Hsiang-Lin Tsai, Ching-Wen Huang, Chih-Jen Huang and Jaw-Yuan Wang
    Citation: Radiation Oncology 2017 12:48
  34. A phase II study was performed to investigate the safety and efficacy of weekly doses of combined paclitaxel and 5-fluorouracil (5-FU) with concurrent radiation therapy, followed by 2 cycles of consolidation c...

    Authors: Yi Xia, Yun-hai Li, Yun Chen, Jun-hua Zhang, Qi Liu, Jia-ying Deng, Ta-shan Ai, Han-ting Zhu, Jian-hong Fan, Harun Badakhshi and Kuai-le Zhao
    Citation: Radiation Oncology 2017 12:47
  35. In patients with isocitrate dehydrogenase (IDH) mutated anaplastic glioma determine the dosimetric benefits of delivering radiation therapy using a PET guided integrated boost IMRT technique (ib-IMRT) compared...

    Authors: M. Back, M. LeMottee, C. Crasta, D. Bailey, H. Wheeler, L. Guo and T. Eade
    Citation: Radiation Oncology 2017 12:46
  36. Standard of care primary treatment of carcinoma of locally advanced squamous cell head and neck cancer (LAHNSCC) consists of platinum-based concomitant chemo-irradiation. Despite progress in the treatment of L...

    Authors: Steffi U. Pigorsch, Jan J. Wilkens, Severin Kampfer, Victoria Kehl, Alexander Hapfelmeier, Christian Schläger, Henning Bier, Markus Schwaiger and Stephanie E. Combs
    Citation: Radiation Oncology 2017 12:45
  37. Current adaptive and dose escalating radiotherapy for muscle invasive bladder cancer requires knowledge of both inter-fractional and intra-fractional motion of the bladder wall involved. The purpose of this st...

    Authors: Kentaro Nishioka, Shinichi Shimizu, Nobuo Shinohara, Yoichi M. Ito, Takashige Abe, Satoru Maruyama, Norio Katoh, Rumiko Kinoshita, Takayuki Hashimoto, Naoki Miyamoto, Rikiya Onimaru and Hiroki Shirato
    Citation: Radiation Oncology 2017 12:44
  38. Brain metastases of gastrointestinal origin are a rare occurrence. Radiation therapy (RT) in the form of stereotactic radiosurgery (SRS) or whole brain radiation therapy (WBRT) is an effective established trea...

    Authors: Samrat M. Sanghvi, Jonathan W. Lischalk, Ling Cai, Sean Collins, Mani Nair, Brain Collins and Keith Unger
    Citation: Radiation Oncology 2017 12:43
  39. This study evaluated the prognosis of patients with extensive-stage small-cell lung cancer (ES-SCLC) that may be associated with timing of thoracic radiotherapy (TRT).

    Authors: Jing Luo, Liming Xu, Lujun Zhao, Yuanjie Cao, Qingsong Pang, Jun Wang, Zhiyong Yuan and Ping Wang
    Citation: Radiation Oncology 2017 12:42
  40. MOSFET dosimetry is a method that has been used to measure in-vivo doses during brachytherapy treatments and during linac based radiotherapy treatment. Rectal displacement devices (RDDs) allow for safe dose es...

    Authors: Kimberley Legge, Peter B. Greer, Daryl J. O’Connor, Lee Wilton, Matthew Richardson, Perry Hunter, Alex Wilfert, Jarad Martin, Anatoly Rosenfeld and Dean Cutajar
    Citation: Radiation Oncology 2017 12:41
  41. It was reported that proton beam therapy (PBT) reduced the normal brain dose compared with X-ray therapy for pediatric brain tumors. We considered whether there was not the condition that PBT was more disadvan...

    Authors: Daichi Takizawa, Masashi Mizumoto, Tetsuya Yamamoto, Yoshiko Oshiro, Hiroko Fukushima, Takashi Fukushima, Toshiyuki Terunuma, Toshiyuki Okumura, Koji Tsuboi and Hideyuki Sakurai
    Citation: Radiation Oncology 2017 12:40
  42. To assess the efficacy of concurrent chemoradiotherapy (CCRT) with daily low-dose cisplatin (CDDP) plus weekly docetaxel (DTX) for patients with T2N0 glottic cancer.

    Authors: Jun-ichi Saitoh, Katsuyuki Shirai, Masumi Imaeda, Atsushi Musha, Takanori Abe, Masato Shino, Yukihiro Takayasu, Katsumasa Takahashi, Kazuaki Chikamatsu and Takashi Nakano
    Citation: Radiation Oncology 2017 12:39
  43. This study evaluated the treatment results of lymph node (LN) oligo-recurrence in esophageal cancer patients treated with salvage radiotherapy (RT) in a multi-institutional retrospective study.

    Authors: Hideomi Yamashita, Keiichi Jingu, Yuzuru Niibe, Kuniaki Katsui, Toshihiko Matsumoto, Tomohiro Nishina and Atsuro Terahara
    Citation: Radiation Oncology 2017 12:38
  44. To report overall survival and local control for patients identified in the RSSearch® Patient Registry with metastatic cancer to the lung treated with SBRT.

    Authors: Anthony Ricco, Joanne Davis, William Rate, Jun Yang, David Perry, John Pablo, David D‘Ambrosio, Sanjeev Sharma, Srinath Sundararaman, James Kolker, Kimberly M. Creach and Rachelle Lanciano
    Citation: Radiation Oncology 2017 12:35
  45. Our previous study suggested that some pulmonary artery (PA) dosimetric parameters were associated with mortality in unresectable non-small cell lung cancer (NSCLC) treated with definitive radiotherapy. The pr...

    Authors: Jie-Tao Ma, Li Sun, Xin Sun, Zhi-Cheng Xiong, Yang Liu, Shu-Ling Zhang, Le-Tian Huang and Cheng-Bo Han
    Citation: Radiation Oncology 2017 12:34
  46. Planning for Volumetric Modulated Arc Therapy (VMAT) may be time consuming and its use is limited by available staff resources. Automated multicriterial treatment planning can eliminate this bottleneck. We com...

    Authors: Daniel Buergy, Abdul Wahab M. Sharfo, Ben J. M. Heijmen, Peter W. J. Voet, Sebastiaan Breedveld, Frederik Wenz, Frank Lohr and Florian Stieler
    Citation: Radiation Oncology 2017 12:33
  47. To evaluate the efficacy and toxicity of helical tomotherapy (HT) in the management of spine chordomas when proton therapy is unavailable or non-feasible.

    Authors: Maxime Bobin, Christina Zacharatou, Paul Sargos, Véronique Brouste, Albert Lisbona, Marc-André Mahé, Georges Noël, Amandine Halley, Loïc Feuvret, Louis Gras, Stéphanie Hoppe, Bénédicte Henriques de Figueiredo and Guy Kantor
    Citation: Radiation Oncology 2017 12:32

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions